CoLucid Pharmaceuticals, Inc.
Neurology-focused pharma announces $16.5 million series A financing
Published in Lab Business Week, February 19th, 2006
The company was formed with a novel, clinical-stage migraine molecule licensed from Eli Lilly & Co. and a portfolio of preclinical assets based on a robust bifunctional neuromodulator chemistry platform, which originated at Sention, Inc. Pappas Ventures seed-funded and formed the company.
The series A financing was co-led by Domain Associates and Pappas Ventures with other investors including Triathlon Medical Ventures and Pearl Street Venture Funds.
The series A funding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-02-19)
More Articles from Lab Business Week
- Avanir Pharmaceuticals
Neurodox maker's board approves implementation of reverse stock split - Business & Finance
The Quantum Group begins generating revenue through community health systems - CRF, Inc.
Clinical trial data company increases revenue by 100% - Cardinal Health, Inc.
Pharmaceutical services company reports earnings per share are up 46% - Celgene Corp.
Thalomid maker posts income of $0.38 per share - Clinical Data, Inc.
Pharmacogenomics company reorganizes to emphasize core business - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
